Press Releases

Vernay Laboratories Brings New Innovations to COMPAMED 2019

October 19, 2019

Vernay Laboratories, a leader in flow control solutions, will be exhibiting its latest developments for the medical market at COMPAMED 2019. The show gathers medical suppliers and product development companies to showcase its expertise, technical capabilities, and innovative solutions within the medical field.

“Vernay is always happy to participate in COMPAMED since it is one of the world’s leading platform for high-tech medical products,” added Andy Woodward, Global Sales & Marketing Vice-president. “The event gives us a chance to highlight our latest developments and the opportunity to interact with existing and potential customers to find out how Vernay can provide a custom fluid control solution to meet their challenges.”

Among the company’s highlights for this year, Vernay will be presenting an innovative technology: Supravalve MAX. The Supravalve MAX is a unique normally closed duckbill valve design that reverses leak protection at low opening pressures while maintaining a consistent, non-tortuous flow path. This new development is an optimal solution for medical flow control applications including: Blood & System Management, Cardiopulmonary System Management, Diagnostic Imaging, Enteral Feeding, Respiratory System Management, Urology, Wound Care Management, and more.

Vernay will also showcase the Supravalve HP, a high-pressure check valve designed to significantly reduce fluid flow turbulence. This valve was specifically developed for use in medical devices where accuracy is critical to success. The Supravalve HP can be customized with various opening pressures through alternative elastomeric inserts according to customer’s requirements.

See us at COMPAMED 2019 in Booth #8AG11 to experience the latest in flow control products. We look forward to provide the right component solution for your next project.

Supravalve MAX from Vernay Laboratories. A unique normally closed duckbill valve.

About Vernay Laboratories, Inc.

Vernay Laboratories has been a technology leader in the design, development, and manufacture of customized flow-control components since its founding in 1946. The company also formulates its own compounds to address each specific application.

Vernay’s products play a vital role in millions of medical devices, automobiles, and consumer products. Today, the privately held firm produces more than 1 billion components per year, drawing from a library of more than 33,000 elastomeric materials and compound formulations. It operates six plants around the world, in the U.S., the Netherlands, Italy and China. For more information, visit